Bay Street News, 2020

Collaboration focused on developing an adjuvanted COVID-19 vaccine using Medigen’s subunit vaccine candidate with Dynavax’s CpG 1018In preclinical testing, the […]

HOUSTON, July 23, 2020 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biotechnology company targeting cancers caused by […]

Clinical hold lifted on seladelpar INDs in NASH, PBC and PSC Re-initiating clinical development focusing first on Phase 3 for PBCNEWARK, […]

TEL AVIV, Israel, July 23, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic […]

New York City, July 23, 2020 (GLOBE NEWSWIRE) — The Chief Executive Officer for BetterLife Pharma Inc. (OTCQB:BETRD) (CSE:BETR), an […]

NEWTOWN, Pa., July 23, 2020 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on […]

NEW YORK, July 23, 2020 (GLOBE NEWSWIRE) — Valley National Bancorp (NASDAQ:VLY), the holding company for Valley National Bank, today […]

GARDEN CITY, N.Y., July 23, 2020 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical […]

Golar Power Limited (“Golar Power”), a joint venture between Golar LNG Limited (NASDAQ ticker: GLNG) and Stonepeak Infrastructure Partners, is […]

NEW YORK, July 23, 2020 (GLOBE NEWSWIRE) — Establishment Labs Holdings Inc. (Nasdaq: ESTA), a medical technology company focused on […]